Royal Society of Chemistry, Nanoscale, 2(3), p. 387-390
DOI: 10.1039/c0nr00436g
Full text: Download
We present the synthesis of trastuzumab-functionalized pegylated iron oxide nanoparticles and provide an FTIR-based approach to gain a direct evidence of the actual conservation of the native structure of conjugated antibody. Their target-selectivity to specific cancer cell receptors has been also assessed.